Table S1.
Drug name (NSC numbera) | IC50 (μmol/L) | ||||
---|---|---|---|---|---|
Cell line | |||||
SEM | B1 | KOPN8 | MOLT-3 | TIB-202 | |
Microtubule stabilizersb | |||||
Docetaxel (628503) | <1.00 × 10−2 | 2.78 × 10−4 | <1.00 × 10−2 | <1.00 × 10−2 | 5.88 × 10−2 |
Paclitaxel (125973) | <1.00 × 10−2 | 8.04 × 10−2 ± 3.49 × 10−2 | <1.00 × 10−2 | 1.00 × 101 | 1.06 × 10−1 |
Microtubule destabilizers | |||||
Vinblastine (49842) | 1.00 × 10−2 | 9.93 × 10−4 | <1.00 × 10−2 | 8.51 × 10−1 | 8.79 × 10−3 |
Vincristine (67574) | <1.00 × 10−2 | 4.42 × 10−2 | <1.00 × 10−2 | 1.00 × 101 | 4.02 × 10−2 |
DNA damaging agents | |||||
Altretamine (13875) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 |
Bleomycin (125066) | <1.00 × 10−2 | 2.92 × 100 ± 2.23 × 100 | 1.08 × 10−1 | 8.42 × 100 | 1.07 × 100 ± 1.84 × 10−1 |
Busulfan (750) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | 6.36 × 100 | >5.00 × 100 |
Carboplatin (241240) | >1.00 × 101 | 7.73 × 100 | 5.14 × 100 | 6.97 × 100 | 7.64 × 100 |
Carmustine (409962) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Chlorambucil (3088) | 7.29 × 100 | 6.41 × 100 | 3.38 × 100 | 5.56 × 100 | 4.47 × 100 |
Cisplatin (119875) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Cyclophosphamide (26271) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Dacarbazine (45388) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 |
Estramustine (702294) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 |
Ifosfamide (109724) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Lomustine (79037) | 9.35 × 100 | 8.32 × 100 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Melphalan (8806) | 5.80 × 100 | 4.08 × 100 | 4.25 × 10−1 | 1.03 × 100 | 2.20 × 100 |
Mitomycin C (26980) | 5.04 × 10−2 | 3.71 × 10−1 ± 5.56 × 10−2 | 5.94 × 10−2 ± 4.38 × 10−2 | 2.21 × 10−2 | 8.55 × 10−2 ± 6.02 × 10−2 |
Nitrogen mustard (762) | 8.83 × 10−1 | 9.58 × 10−1 | 1.99 × 100 | >1.00 × 101 | 3.42 × 100 |
Oxaliplatin (266046) | 5.67 × 100 | 3.68 × 100 | 3.09 × 10−1 | 9.69 × 10−1 | 6.20 × 100 |
Pipobroman (25154) | 4.32 × 100 | 2.63 × 100 | 3.89 × 10−1 | 6.35 × 100 | 4.34 × 100 |
Procarbazine (77213) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Streptozocin (85998) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Temozolomide (362856) | 9.12 × 100 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Thiotepa (6396) | 3.78 × 100 | 6.38 × 100 | 1.96 × 100 | 3.01 × 100 | 5.00 × 100 |
Triethylenemelamine (9706) | 4.81 × 10−1 | 3.97 × 10−1 | 1.97 × 10−1 | 2.60 × 10−1 | 4.47 × 10−1 |
Uracil mustard (34462) | 4.85 × 100 | 3.65 × 100 | 2.22 × 100 | 9.66 × 100 | 2.70 × 100 |
DNA intercalating agents | |||||
Dactinomycin (3053) | <1.00 × 10−2 | <1.00 × 10−2 | <1.00 × 10−10 | <1.00 × 10−2 | <1.00 × 10−5 |
Daunorubicin (82151) | <1.00 × 10−2 | 9.45 × 10−3 ± 1.92 × 10−3 | <5.00 × 10−3 | <1.00 × 10−2 | 1.08 × 10−2 |
Doxorubicin (123127) | <1.00 × 10−2 | 1.20 × 10−1 ± 1.41 × 10−1 | <1.00 × 10−2 | 7.84 × 100 | 5.85 × 10−2 |
Mitoxantrone (279836) | <1.00 × 10−2 | <1.00 × 10−2 | <1.00 × 10−2 | 3.42 × 10−1 | <1.00 × 10−2 |
Nucleic acid synthesis inhibitors | |||||
Capecitabine (712807) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 |
Clofarabine (606869) | 2.58 × 10−2 | <1.00 × 10−2 | 8.70 × 10−3 | >1.00 × 101 | <1.00 × 10−2 |
Floxuridine (27640) | >1.00 × 101 | 8.48 × 100 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Fludarabine (312887) | 8.87 × 10−2 | 9.09 × 10−2 | 7.05 × 10−2 | >1.00 × 101 | 7.31 × 10−2 |
Fluorouracil (19893) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | 7.11 × 100 | >5.00 × 100 |
Gemcitabine (613327) | <1.00 × 10−2 | 2.57 × 10−2 ± 1.03 × 10−2 | <5.00 × 10−3 | <1.00 × 10−2 | 5.65 × 10−2 ± 7.28 × 10−2 |
Hydroxyurea (32065) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Mercaptopurine (755) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Nelarabine (686673) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | 1.23 × 100 | >1.00 × 101 |
Pemetrexed (698037) | >1.00 × 101 | 6.71 × 10−1 | 1.58 × 10−1 | 5.67 × 10−1 | 1.79 × 10−1 |
Pentostatin (218321) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Thioguanine (752) | 9.38 × 10−1 | 8.77 × 100 | 4.50 × 100 | 7.05 × 100 | 5.20 × 100 |
Aromatase inhibitors | |||||
Anastrozole (719344) | 2.08 × 100 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 |
Exemestane (713563) | 2.08 × 100 | >1.00 × 101 | 8.89 × 100 | >1.00 × 101 | >1.00 × 101 |
Letrozole (719345) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 |
DNA methyltransferase inhibitors | |||||
Azacitidine (102816) | 1.30 × 100 | 5.07 × 100 | 8.36 × 10−1 | 6.21 × 100 | 5.20 × 100 |
Histone deacetylase inhibitors | |||||
Vorinostat (701852) | >1.00 × 101 | 3.82 × 100 | 4.16 × 10−1 | 5.67 × 10−1 | 4.30 × 100 |
mTOR inhibitors | |||||
Everolimus (733504) | <1.00 × 10−2 | 8.34 × 10−1 | <1.00 × 10−2 | >1.00 × 101 | <1.00 × 10−2 |
Rapamycin (226080) | <1.00 × 10−2 | 8.04 × 10−3 | <1.00 × 10−2 | <1.00 × 10−2 | 7.05 × 100 ± 4.17 × 100 |
Proteasome inhibitors | |||||
Bortezomib (681239) | <1.00 × 10−2 | 3.97 × 10−3 | <1.00 × 10−2 | >1.00 × 101 | 5.71 × 10−3 |
Tyrosine kinase inhibitors | |||||
Dasatinib (732517) | 4.05 × 100 | <1.00 × 10−6 | 7.48 × 10−3 | >1.00 × 101 | <1.00 × 10−6 |
Imatinib (743414) | 7.68 × 100 | 2.06 × 10−1 ± 1.34 × 10−2 | >1.00 × 101 | >1.00 × 101 | 2.70 × 10−1 ± 3.07 × 10−1 |
Lapatinib (745750) | 4.73 × 100 | 5.70 × 100 | 5.20 × 100 | >1.00 × 101 | 7.42 × 100 |
Nilotinib (747599) | >1.00 × 101 | <1.00 × 10−2 | >1.00 × 101 | >1.00 × 101 | <1.00 × 10−2 |
Sorafenib (747971) | 1.54 × 100 | 5.66 × 100 | 3.86 × 100 | 9.63 × 100 | 5.95 × 100 |
Sunitinib (750690) | 1.35 × 10−1 | 5.36 × 100 | 3.30 × 100 | >1.00 × 101 | 3.29 × 100 |
Topoisomerase poisons | |||||
Etoposide (141540) | 9.28 × 10−2 | 7.10 × 10−1 ± 5.81 × 10−1 | 1.97 × 10−2 | 1.07 × 10−1 | 4.56 × 10−1 ± 3.12 × 10−1 |
Irinotecan (616348) | 3.40 × 100 | 2.29 × 100 | 1.69 × 100 | 3.92 × 100 | 2.53 × 100 |
Teniposide (122819) | 9.28 × 10−3 | 2.98 × 10−2 ± 3.09 × 10−2 | 1.80 × 10−4 | 1.17 × 10−2 | 4.91 × 10−2 ± 3.08 × 10−2 |
Topotecan (609699) | <1.00 × 10−2 | 2.76 × 10−2 ± 3.85 × 10−2 | <1.00 × 10−2 | <1.00 × 10−2 | 4.53 × 10−2 |
EGFR inhibitors | |||||
Erlotinib (718781) | 1.00 × 100 | 2.98 × 100 | 5.82 × 100 | 5.70 × 100 | 6.68 × 100 |
Gefitinib (715055) | 4.89 × 100 | 5.16 × 100 | 5.08 × 100 | >1.00 × 101 | 9.28 × 100 |
Estrogen receptor modulators | |||||
Fulvestrant (719276) | >1.00 × 101 | >1.00 × 101 | 7.64 × 100 | >1.00 × 101 | >1.00 × 101 |
Raloxifene (747974) | 4.44 × 100 | >1.00 × 101 | 8.30 × 100 | >1.00 × 101 | >1.00 × 101 |
Tamoxifen (180973) | >1.00 × 101 | 6.45 × 100 | 2.70 × 100 | 1.00 × 101 | >5.00 × 100 |
Immunomodulatory agents | |||||
Imiquimod (369100) | >1.00 × 101 | >1.00 × 101 | 2.90 × 100 | >1.00 × 101 | >1.00 × 101 |
Lenalidomide (747972) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | 1.00 × 101 | >1.00 × 101 |
Thalidomide (66847) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Photo-activated agents | |||||
Aminolevulinic acid (18509) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 |
Methoxsalen (45923) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Protective adjuvant drugs | |||||
Allopurinol (1390) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Amifostine (296961) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 |
Dexrazoxone (169780) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Zoledronic acid (721517) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 |
Miscellaneous drugs | |||||
Acrichine (14229) | 6.40 × 100 | 4.63 × 100 | 7.22 × 10−1 | 4.07 × 100 | 4.50 × 100 |
Arsenic trioxide (92859) | >1.00 × 101 | >1.00 × 101 | 1.69 × 10−1 | >1.00 × 101 | >1.00 × 101 |
Celecoxib (719627) | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 | >1.00 × 101 |
Megestrol acetate (71423) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Mitotane (38721) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Tretinoin (122758) | >1.00 × 101 | >1.00 × 101 | >5.00 × 100 | >1.00 × 101 | >5.00 × 100 |
Notes:
Compound identification number in the National Cancer Institute/National Institutes of Health Developmental Therapeutics Program database;
Some drugs may have more than one mechanism of action.
Abbreviation: IC50, half maximal inhibitory concentration.